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Introduction:  Obstructive  Sleep  Apnea  (OSA)  is  characterized  by  recurrent  episodes  of  apnea
and hypopnea,  secondary  to  collapse  of  the  upper  airways  during  sleep.  OSA  is  frequently
associated  to  cardiovascular  complications.  In  Portugal,  its  magnitude  is  unknown.
Methods: In  2014  a  cross-sectional  study  was  performed  using  the  Portuguese  General  Practi-
tioner (GP)  Sentinel  Network  (Rede  Médicos  Sentinela).  Participants  GP  reported  all  OSA  cases
diagnosed  and  registered  in  their  lists  of  users  on  the  31  December  2013.
Frequency  of  OSA  has  been  estimated  by  sex  and  age.  OSA  patients  were  also  characterized
by method  of  diagnosis,  treatment,  and  underlying  conditions.
Association  between  risk  factors  and  severe  OSA  (odds  ratio)  was  calculated  using  a  logistic
regression  model  adjusting  confounding.
Results:  Prevalence  of  OSA  on  the  population  aged  25  years  or  more  was  0.89%  (95  CI:
0.80--1.00%);  it  was  higher  in  males  1.47%  (95  CI:  1.30--1.67%)  and  in  those  aged  between  65  and
74 (2.35%).  Most  had  severe  OSA  (48.4%).  Hypertension  (75.9%),  obesity  (74.2%)  and  diabetes
mellitus (34.1%)  were  the  most  frequent  comorbidities.  Being  a  male  (OR:  2.6;  95  CI:  1.2--5.8)
and having  obesity  (OR:  4.0;  95  CI:  1.8--8.6)  were  associated  with  an  increased  risk  of  severe
OSA.
Conclusion:  Found  frequency  of  OSA  was  lower  than  other  countries  estimates,  which  may  be
explained by  differences  on  case  definition  but  can  also  suggest  underdiagnosis  of  this  condition
as reported  by  other  authors.
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under  observation  of  34,909  individuals  (Table  1).  All  the  GP
that  accepted  participating  in  the  study  sent  information8  
ntroduction
he  Obstructive  Sleep  Apnea  (OSA)  is  characterized  by
ecurrent  episodes  of  apnea  or  hypopnea  secondary  to  a
ollapse  of  the  upper  airways  during  sleep.
A  wide  variability  in  OSA  prevalence  is  found  between
tudies  due  to  important  differences  in  cases  definition  and
tudy  population.1
It  is  estimated  that  the  prevalence  of  OSA  (defined  by
he  presence  of  episodes  of  hypopnea  and  apnea  and  fre-
uent  daytime  sleepiness)  in  adult  men  vary  between  1%
nd  5%.1 Considering  OSA  definition  currently  used  (occur-
ence  of  more  than  5  episodes  of  apnea  and  hypopnea  per
our),  prevalence  of  OSA,  accordingly  sex  and  age  group,
an  vary  between  2%  and  28%,  half  of  which  is  classified  as
oderate  or  severe.2,3 Prevalence  of  undiagnosed  OSA  may
ange  between  0.3%  and  5%.4
As  OSA  affects  mainly  middle-aged  and  obese  males,5 it
s  recognized  that  the  increase  in  obesity  may  contribute  to
n  increase  in  OSA  prevalence.
In  addition  to  its  high  magnitude,  the  clinical  importance
f  OSA  comes  from  its  cardiovascular  effects,  consequences
n  morbidity  and  mortality6,7 and  also  neuropsychological
hanges  that  increase  the  occurrence  of  occupational  and
raffic  accidents.8 OSA  is  a  risk  factor  for  hypertension  and
t  is  also  known  that  high  blood  pressure  risk  increases  with
everity  of  OSA.9 In  fact,  given  the  high  frequency  of  OSA
ithin  individuals  with  hypertension,10 the  latest  standard
or  hypertension  diagnostic  approach  recommends  perform-
ng  OSA  diagnosis  in  cases  of  high  blood  pressure  which  are
esistant  to  treatment  and  have  a  non-dipper  pattern  on  24  h
ecords  of  blood  pressure.11,12 It  is  also  known  that  preva-
ence  of  sleep-disordered  breathing  among  patients  who  had
trokes  is  high,  ranging  between  44%  and  74%,13 emphasizing
hat  the  presence  of  OSA  in  these  patients  is  associated  with
n  increased  risk  of  premature  mortality.14
The  association  between  Diabetes  and  OSA  has  recently
een  described  and  there  is  emerging  evidence  that  OSA
onstitutes  a  risk  factor  for  development  of  resistance  to
nsulin15 independently  of  obesity,  which  may  be  involved  in
etabolic  syndrome  development.16
Another  aspect  that  reinforces  the  importance  of  the
iagnosis  of  OSA  is  linked  to  the  efficacy  of  nasal  Contin-
ous  Positive  Airway  Pressure  (CPAP)  therapy  in  reversing
europsychological  disorders  and  reducing  cardiovascular
vents.17 As  a  consequence  of  CPAP  treatment,  reduction
f  excessive  daytime  sleepiness  contributes  to  quality  of  life
mprovement  and  accident  risk  reduction  but  also  the  occur-
ence  of  high  blood  pressure  is  clearly  lower  in  the  short  and
ong  term.18
Although  Portuguese  prevalence  of  OSA  is  unknown,
onsidering  the  high  prevalence  of  adult  obesity  in  Portugal19
 high  prevalence  of  OSA  can  be  expected  in  the  adult  Por-
uguese  population.  Neither  is  the  patient  profile  with  OSA
nown,  especially  in  terms  of  severity,  treatment,  comor-
idities  and  use  of  health  services.
As  it  is  not  currently  feasible  to  implement  a  popula-
ion  based  survey  to  estimate  the  Portuguese  prevalence  of
SA,  the  first  approach  to  the  subject  is  to  estimate  the
requency  of  OSA  known  within  the  population  under  obser-
ation  of  the  General  Practitioner  (GP)  Sentinel  Network  and
o  characterize  OSA  patients.
r
t
A.P.  Rodrigues  et  al.
aterial and methods
 cross  sectional  study  was  performed  within  the  GP  Sen-
inel  Network  (known  as  Rede  Médicos  Sentinela), which  has
ational  distribution  and  117  GP  in  2013.
At  the  beginning  of  the  study  all  Sentinel  GP  included
n  the  Rede  Médicos  Sentinela  in  2013  and  also  GPs  that
oined  the  network  in  the  first  trimester  of  2014  (a  total  of
)  were  invited  to  participate.  Invitation  was  sent  by  email
nd  renewed  by  phone  call.  The  study  protocol,  question-
aire  forms  and  detailed  study  instructions  were  sent  to  all
octors  that  accepted  to  take  part  in  the  study.
GP  participation  consisted  in  filling  in  a  questionnaire  for
ach  and  all  of  their  patients  diagnosed  with  OSA  at  31st  of
ecember  of  2013,  using  existing  recorded  information  data
o  collect  following  data:
.  Sex  and  age.
.  Diagnostic,  including:  diagnostic  date,  overnight  poly-
somnography  or  overnight  respiratory  polygraphy  per-
formance,  apnea--hypopnea  index,  respiratory  disturb
index.
.  Comorbidities:  diabetes,  high  blood  pressure,  obesity,
coronary  disease,  stroke,  acute  myocardial  infarction,
arrhythmia,  heart  failure,  occurrence  of  traffic  accident
(as  driver).
.  Treatment:  CPAP,  specialized  sleep  medical  appoint-
ment.
An  OSA  case  was  defined  as  someone  having  a  previous
iagnosis  of  OSA  performed  by  a  specialist  and  known  by  the
atient’s  family  doctor.
A  Severe  OSA  was  defined  as  someone  having  an
pnea--hypopnea  index  or  respiratory  disturb  index  equal  or
igher  than  30.
Proportion  of  OSA  was  estimated  by  sex  and  age  group
sing  the  sum  of  users  aged  25  years  and  more  followed
y  each  participating  GP  as  denominator  (total  of  34,909
ndividuals  that  comprises  the  study  sample).
95  Confidence  intervals  (95  CI)  were  computed  using  Wil-
on  method.20 No  estimates  were  presented  for  age  groups
ith  less  than  5  cases.
Mean  (and  95  CI)  and  median  were  computed  for  numeric
ariables;  proportions  (and  95  CI)  for  categorical  variables.
2 test  was  used  to  identify  variables  associated  to  severe
SA  and  a  logistic  regression  model,  using  all  variables  in
hich  2 significant  level  was  <0.20,  was  performed  to  esti-
ate  adjusted  Odds  Ratio  (and  95  CI)  of  having  severe  OSA
mong  all  OSA  patients.
Model  assumptions  of  the  final  regression  model  were
hecked  by  residual  analysis.  Hosmer  and  Lemeshow  test
as  used  to  check  the  goodness  of  the  final  regression
odel.
esults
9  (of  124)  GP  agreed  to  participate,  giving  a  populationelating  to  OSA  cases,  which  corresponds  to  a  100%  par-
icipation  rate.  In  relation  to  sex  and  age  distribution,  no
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Table  1  Study  population  by  sex  and  age  group.
Age  group  (years)  Male  %  Female  %  Total  %
25--34 2,967  48.5  3,154  51.5  6,121  17.5
35--44 3,426  47.1  3,847  52.9  7,273  20.8
45--54 3,065  47.3  3,419  52.7  6,484  18.6
55--64 2,726  46.6  3,119  53.4  5,845  16.7
65--74 2,189  45.9  2,582  54.1  4,771  13.7
≥75 1,699  38.5  2,716  61.5  4,415  12.6
Total 16,072  46.0  18,837  54.0  34,909  100.0
Table  2  Distribution  of  Obstructive  Sleep  Apnea  by  sex  and  age.
Age  group  (years)  Male  Female  Total
F  %  95  CI  F  %  95  CI  F  %  95  CI
25--34  3 a  a 0  0 a 3 a  a
35--44  10  0.29  0.16--0.54  7  0.18  0.09--0.38  17  0.23  0.15--0.37
45--54 34  1.11  0.79--1.54  14  0.41  0.24--0.69  48  0.74  0.56--0.98
55--64 73  2.68  2.14--3.36  16  0.51  0.32--0.83  89  1.52  1.24--1.87
65--74 88  4.02  3.28--4.93  24  0.93  0.63--1.38  112  2.35  1.95--2.82
≥75 29  1.71  1.19--2.44  13  0.48  0.28--0.82  42  0.95  0.71--1.28
Total 237  1.47  1.30--1.67  74  0.39  0.31--0.49  311  0.89  0.80--1.00
Note: F -- frequency, 95 CI -- 95% confidence interval.
a Less than 5.
Table  3  Comorbidities.
Comorbidities  N  F  (%) 95  CI
Obesity  302  224  (74.2)  69.0--78.8
High blood  pressure  303  230  (75.9)  70.8--80.4
Diabetes  mellitus  305  104  (34.1)  29.0--39.6
Arrhythmia  294  35  (11.9)  8.7--16.1
Traffic accident  248  21  (8.5)  5.6--12.6
Coronary  disease 294  33  (11.2)  8.1--15.3
Heart failure 295  28  (9.5)  6.6--13.4
Stroke 297  18  (6.1)  3.9--9.4
Acute myocardial  infarction  295  19  (6.4)  4.2--9.8
Continuous  positive  airway  pressure  treatment  was  pre-
scribed  to  89.6%  of  all  patients  (95  CI:  85.7--92.6),  being
this  proportion  higher  (96.1%)  for  those  who  had  a  severe
clinical  condition.
High  blood  pressure  (75.9%),  obesity  (74.2%)  and  diabetes
mellitus  (34.1%)  were  the  most  frequent  comorbidities  in
OSA  patients  (Table  3).
In  relation  to  OSA  severity,  it  was  found  that  being  male
(OR:  2.6;  95  CI:  1.2--5.8)  and  obese  (OR:  4.0;  95  CI:  1.8--8.6)
showed  an  association  to  a  higher  risk  of  having  severe  dis-
ease  among  all  OSA  patients  (Table  4).
Discussion
Prevalence  of  Obstructive  Sleep  Apnea
Although  this  study  focused  only  on  diagnosed  OSA  cases  by
family  doctors,  the  low  prevalence  of  OSA  (0.89%)  found  sug-
gests  that  like  other  studies2--4,8,21 this  clinical  condition  is
actually  underdiagnosed.  Nevertheless,  as  case  identifica-
tion  was  performed  using  medical  registries  that  use  the
second  version  of  the  International  Classification  for  Primary
Table  4  Risk  factors  of  Severe  Obstructive  Sleep  Apnea.
OR  (adjusted)  95  CI  p-value
Male  2.6  1.2--5.8  0.017
Obesity 4.0 1.8--8.6  <0.001Note: N -- number of valid observations, F -- frequency, 95 CI --
95% confidence interval.
differences  were  found  between  the  study  population  and
the  Portuguese  population  (Supplementary  material).
311  cases  of  OSA  were  identified  in  that  population;  the
average  age  was  62.8  years  (95  CI:  61.6--64.1)  and  no  age
difference  was  found  between  sexes.
Proportion  of  cases  aged  25  years  and  more  has  been
0.89%  (95  CI:  0.80--1.00).  A  higher  proportion  of  OSA  was
found  in  males,  namely  between  65  and  74  years  (4.02%;  95
CI:  3.28--4.93)  (see  Table  2).
97.3%  (95  CI:  94.5--98.7)  of  all  cases  had  undergone
sleep  study  and  of  those  56.2%  had  undergone  polysomno-
graphy.  48.4%  (95  CI:  40.8--56.1)  had  a  severe  disease  (AHI
or  RDI  ≥  30)  and  only  17.6%  (95  CI:  12.5--24.3)  had  a  mild
disease  [5≤(AHI  or  RDI)<15].
More  than  half  of  the  cases  (59.5%;  95  CI:  53.8--65.0)
were  followed  through  specialized  medical  appointments.
Note: OR adjusted by sex, obesity. OR -- odds ratio, 95 CI -- 95%
confidence interval.
Hosmer and Lemeshow p-value: 0.544.
60  
Table  5  Proportion  of  severe  cases.
Study  Severe  cases  (%)
Male  Female
Young  et  al.a 37.9  44.4






















































































Note: Proportions computed from prevalence values of OSA.
a Includes moderate and severe cases (AHI ≥ 15).
are  (ICPC2)  we  cannot  exclude  the  effect  of  the  registries’
haracteristics  during  the  case  identification  process.
On  the  other  hand,  compared  to  other  countries2,3
Table  5)  a  higher  proportion  of  severe  cases  was  found  on
ur  study  (48.4%),  which  suggests  that  OSA  patients  known  in
rimary  health  care  setting  are  those  with  a  severe  clinical
resentation.  The  legal  requirement  for  a  treatment  pre-
cription  performed  by  a  medical  doctor  within  the  National
ealth  System  is  probably  favors  a  better  knowledge  of
evere  cases.
Considering  the  hypothesis  of  underdiagonis  and  accept-
ng  the  fact  that  severe  cases  represents  20%  of  all  OSA  cases
a  similar  value  was  found  in  Spain3),  OSA  prevalence  at
opulation  level  (aged  25  years  and  more)  could  be  around
.2%,  which  is  still  lower  than  that  found  in  USA2 (4%  male,
%  female)  and  Spain3 (26.2%  male,  28.0%  female).  Sev-
ral  methodological  differences  between  studies  were  found
namely  in  sampling  framework,  age  groups,  case  selec-
ion  and  case  definition1--3,21)  that  limit  data  comparability.
evertheless,  as  case  definition  used  in  Young  et  al.  study2
ncludes  the  presence  of  symptoms  of  OSA  and  an  AHI  ≥  5,
e  considered  that  it  can  be  closer  to  the  case  definition
sed  in  this  study  than  that  used  by  Durán  et  al.3 However,
iven  our  case  definition  (previous  diagnosis  performed  by
 specialist  and  known  by  the  patient’s  family  doctor),  a
election  bias  cannot  be  excluded  if  OSA  diagnosis  had  been
ore  frequently  made  in  male  patients,  which  may  explain
 higher  sex  ratio  estimate  (3.8  male:1.0  female)  than  that
bserved  by  Young  et  al.2 (3:1).
The  highest  prevalence  of  OSA  for  both  sexes  found
etween  65  and  74  years  of  age  can  indicate  a  late  diag-
ose  of  OSA  when  compared  to  other  study  which  show  that
he  highest  prevalence  in  men  was  observed  between  the
th  and  6th  decades  of  life.22 These  results  highlight  the
ypothesis  of  underdiagnosis  of  OSA,  namely  among  young
nd  less  health  care  consumer  population.
omorbidities
he  underlying  conditions  observed  in  our  OSA  patients  were
hose  frequently  associated  to  OSA  as  risk  factors  (obesity)
r  as  complications  (DM  and  high  blood  pressure).3,8,10,15,23--25
s  expected,  the  proportion  of  OSA  patients  suffering  high
lood  pressure  (75.9%)  is  higher  than  the  prevalence  of  high
lood  pressure  observed  in  the  adult  Portuguese  population
42%).26 Nevertheless,  contrary  to  what  has  been  suggested
y  other  studies,10,23,24 no  association  between  high  blood
ressure  and  OSA  severity  was  found  which  can  be  explained
y  the  high  proportion  of  cases  with  high  blood  pressure
nd  the  reduced  number  of  cases  (n  =  311).  Also  the  high
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articipants  could  contribute  to  this  null  association  as  high
lood  pressure  is  less  associated  to  severe  OSA  within  older
nd  obese  patients.8
The  association  of  male  sex,  obesity  and  severe  OSA
ound  is  compatible  with  the  role  of  these  factors  in  the
athogenesis  of  the  disease  described  elsewhere.2
imitations
s  a  limitation,  it  is  important  to  mention  that  the  study  set-
ing  and  case  definition  used  only  permitted  us  to  estimate
he  proportion  of  users  of  primary  care  suffering  from  OSA
nstead  of  an  estimate  of  the  real  prevalence  of  OSA.  Despite
he  large  sample  size  used  and  its  similar  demographic
tructure,  when  compared  to  the  Portuguese  population,
he  distribution  of  participating  GP  does  not  guarantee  a
ational  representativeness  of  the  sample.
onclusions
s  far  as  we  know,  this  was  the  first  approach  to  working
ut  the  burden  of  this  disease  on  the  Portuguese  popula-
ion.  Our  research  found  a  low  prevalence  of  OSA  within  the
ortuguese  population  aged  25  years  and  more,  which  may
ndicate  an  underdiagnosis  of  this  health  condition.
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